15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial.

Bethlehem L, Bartu L, Marke G, Mar P, Feldman S, Eggers J, Ruprecht C, Britton GJ, Aggarwala V, Bongers G, Li Z, Yang N, Hohmann EL, Mogno I, Faith JJ, Grinspan A

Open source

DOI
10.1038/s41591-026-04442-2
Published
2026 Jul
Container
Nature medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04442-2,
  title = {15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial.},
  author = {Bethlehem L and Bartu L and Marke G and Mar P and Feldman S and Eggers J and Ruprecht C and Britton GJ and Aggarwala V and Bongers G and Li Z and Yang N and Hohmann EL and Mogno I and Faith JJ and Grinspan A},
  year = {2026},
  journal = {Nature medicine},
  doi = {10.1038/s41591-026-04442-2},
  url = {https://doi.org/10.1038/s41591-026-04442-2}
}

RIS

TY  - JOUR
TI  - 15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial.
AU  - Bethlehem L
AU  - Bartu L
AU  - Marke G
AU  - Mar P
AU  - Feldman S
AU  - Eggers J
AU  - Ruprecht C
AU  - Britton GJ
AU  - Aggarwala V
AU  - Bongers G
AU  - Li Z
AU  - Yang N
AU  - Hohmann EL
AU  - Mogno I
AU  - Faith JJ
AU  - Grinspan A
PY  - 2026
JO  - Nature medicine
DO  - 10.1038/s41591-026-04442-2
UR  - https://doi.org/10.1038/s41591-026-04442-2
ER  - 

APA

L, B., L, B., G, M., P, M., S, F., J, E., C, R., GJ, B., V, A., G, B., Z, L., N, Y., EL, H., I, M., JJ, F., & A, G. (2026). 15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial.. Nature medicine. https://doi.org/10.1038/s41591-026-04442-2

Source records